Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Yimitasvir + Sofosbuvir in Chronic Genotype 1 HCV
NCT03458481Phase 2Completed
- Sponsor
- Sunshine Lake Pharma
- Start
- Jul 2017
- Primary completion
- May 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of yimitasvir in hepatitis C (HCV), sponsored by Sunshine Lake Pharma. Started Jul 2017; status: completed.
02
Drugs
yimitasvir
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT03458481.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03458481.